THOMAS CHUNG: Open Payments
NPI 1114378171 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 14 payments from 8 companies in 2025. Trend: 2023 $2,028 · 2024 $629 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| PFIZER INC. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Medtronic, Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| AtriCure, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $16 |
Products named: Repatha, Kerendia, ELIQUIS, SYMPLICITY G3, JARDIANCE, LEQVIO, ATRICLIP LAA EXCLUSION SYSTEM, ENTRESTO.
Industry payments across CA — which companies pay providers there.
